Exploration and validation of a novel prognostic signature based on comprehensive bioinformatics analysis in hepatocellular carcinoma
Open Access
- 13 November 2020
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 40 (11)
- https://doi.org/10.1042/bsr20203263
Abstract
The present study aimed to construct a novel signature for indicating the prognostic outcomes of hepatocellular carcinoma (HCC). Gene expression profiles were downloaded from Gene Expression Omnibus (GEO), The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) databases. The prognosis-related genes with differential expression were identified with weighted gene co-expression network analysis (WGCNA), univariate analysis, the least absolute shrinkage and selection operator (LASSO). With the stepwise regression analysis, a risk score was constructed based on the expression levels of five genes: Risk score = (−0.7736* CCNB2) + (1.0083* DYNC1LI1) + (−0.6755* KIF11) + (0.9588* SPC25) + (1.5237* KIF18A), which can be applied as a signature for predicting the prognosis of HCC patients. The prediction capacity of the risk score for overall survival was validated with both TCGA and ICGC cohorts. The 1-, 3- and 5-year ROC curves were plotted, in which the AUC was 0.842, 0.726 and 0.699 in TCGA cohort and 0.734, 0.691 and 0.700 in ICGC cohort, respectively. Moreover, the expression levels of the five genes were determined in clinical tumor and normal specimens with immunohistochemistry. The novel signature has exhibited good prediction efficacy for the overall survival of HCC patients.Keywords
This publication has 34 references indexed in Scilit:
- Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinomaJournal of Cancer Research and Therapeutics, 2017
- Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinomaClinica Chimica Acta; International Journal of Clinical Chemistry, 2016
- Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular CarcinomaGastroenterology, 2016
- Cancer statistics, 2016CA: A Cancer Journal for Clinicians, 2016
- Profiling of somatic mutations in acute myeloid leukemia with FLT3-ITD at diagnosis and relapseBlood, 2015
- Genetic Landscape and Biomarkers of Hepatocellular CarcinomaGastroenterology, 2015
- The evolving epidemiology of hepatocellular carcinoma: a global perspectiveExpert Review of Gastroenterology & Hepatology, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinomaOncotarget, 2014
- New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic ChemotherapyJournal of Clinical Oncology, 2009